AU Patent

AU2014277831C1 — Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates

Assigned to Shionogi and Co Ltd · Expires 2022-10-06 · 4y expired

What this patent protects

A salt or a hydrate thereof of a compound of formula AA OH 0 CH3 F 0 5 FN H 5 F 0AA

USPTO Abstract

A salt or a hydrate thereof of a compound of formula AA OH 0 CH3 F 0 5 FN H 5 F 0AA

Drugs covered by this patent

cabotegravir-sodium (CABOTEGRAVIR SODIUM)

Patent Metadata

Patent number: AU2014277831C1
Jurisdiction: AU
Classification: —
Expires: 2022-10-06
Drug substance claim: No
Drug product claim: No
Assignee: Shionogi and Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.